Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease
Neuroactive steroids are known neuroprotective agents and neurotransmitter regulators. We previously found that expression of the enzymes synthesizing 5α-dihydroprogesterone (5α-DHP), allopregnanolone (ALLO), and dehydroepiandrosterone sulfate (DHEAS) were reduced in the substantia nigra (SN) of Par...
Main Authors: | Sabina Luchetti, Philippe Liere, Antoine Pianos, Ronald W.H. Verwer, Arja Sluiter, Inge Huitinga, Michael Schumacher, Dick F. Swaab, Matthew R.J. Mason |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996123001845 |
Similar Items
-
Diabetic Encephalopathy in a Preclinical Experimental Model of Type 1 Diabetes Mellitus: Observations in Adult Female Rat
by: Eva Falvo, et al.
Published: (2023-01-01) -
Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant
by: Rachida Guennoun
Published: (2020-07-01) -
Allopregnanolone: Regenerative therapeutic to restore neurological health
by: Gerson D. Hernandez, et al.
Published: (2022-11-01) -
Neurosteroids and Focal Epileptic Disorders
by: Maxime Lévesque, et al.
Published: (2020-12-01) -
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
by: Marcia H. Ratner, et al.
Published: (2019-04-01)